The $1.59 Is The Price At Which Compugen Ltd (NASDAQ: CGEN) Deserves Consideration
During the last session, Compugen Ltd (NASDAQ:CGEN)’s traded shares were 0.33 million, with the beta value of the company hitting 2.63. At the end of
During the last session, Compugen Ltd (NASDAQ:CGEN)’s traded shares were 0.33 million, with the beta value of the company hitting 2.63. At the end of
During the last session, Co-Diagnostics Inc (NASDAQ:CODX)’s traded shares were 0.47 million, with the beta value of the company hitting 0.53. The 52-week high for
During the last session, Silexion Therapeutics Corp (NASDAQ:SLXN)’s traded shares were 0.3 million, with the beta value of the company hitting 0.05. At the end
During the last session, OLB Group Inc (NASDAQ:OLB)’s traded shares were 0.35 million, with the beta value of the company hitting 1.86. At the end
During the last session, Evoke Pharma Inc (NASDAQ:EVOK)’s traded shares were 0.63 million, with the beta value of the company hitting -0.07. At the end
During the last session, Sotera Health Co (NASDAQ:SHC)’s traded shares were 0.81 million, with the beta value of the company hitting 1.81. At the end
During the last session, Liberty Broadband Corp (NASDAQ:LBRDK)’s traded shares were 0.88 million, with the beta value of the company hitting 0.99. At the end
During the last session, Qifu Technology Inc. ADR (NASDAQ:QFIN)’s traded shares were 0.8 million, with the beta value of the company hitting 0.47. At the
During the last session, Terreno Realty Corp (NYSE:TRNO)’s traded shares were 0.89 million, with the beta value of the company hitting 1.04. At the end
During the last session, Pilgrim’s Pride Corp (NASDAQ:PPC)’s traded shares were 0.86 million, with the beta value of the company hitting 0.50. At the end
© 2024, Powered by Smart TechOne